Search

Your search keyword '"Testi, Ilaria"' showing total 240 results
Start Over Author "Testi, Ilaria"
240 results on '"Testi, Ilaria"'

1. The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 2—global current practice patterns for the management of Cytomegalovirus anterior uveitis

Author

Thng, Zheng Xian, Putera, Ikhwanuliman, Testi, Ilaria, Chan, Kevin, Westcott, Mark, Chee, Soon-Phaik, Dick, Andrew D., Kempen, John H., Bodaghi, Bahram, Thorne, Jennifer E., Barisani-Asenbauer, Talin, de Smet, Marc D., Smith, Justine R., McCluskey, Peter, La Distia Nora, Rina, Jabs, Douglas A., de Boer, Joke H., Sen, H. Nida, Goldstein, Debra A., Khairallah, Moncef, Davis, Janet L., Rosenbaum, James T., Jones, Nicholas P., Nguyen, Quan Dong, Pavesio, Carlos, Agrawal, Rupesh, and Gupta, Vishali

Published
2024
Full Text
View/download PDF

2. The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1—global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitis

Author

Thng, Zheng Xian, Putera, Ikhwanuliman, Testi, Ilaria, Chan, Kevin, Westcott, Mark, Chee, Soon-Phaik, Dick, Andrew D., Kempen, John H., Bodaghi, Bahram, Thorne, Jennifer E., Barisani-Asenbauer, Talin, de Smet, Marc D., Smith, Justine R., McCluskey, Peter, La Distia Nora, Rina, Jabs, Douglas A., de Boer, Joke H., Sen, H. Nida, Goldstein, Debra A., Khairallah, Moncef, Davis, Janet L., Rosenbaum, James T., Jones, Nicholas P., Nguyen, Quan Dong, Pavesio, Carlos, Agrawal, Rupesh, and Gupta, Vishali

Published
2024
Full Text
View/download PDF

6. Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

Author

Agrawal, Rupesh, Testi, Ilaria, Lee, Cecilia S, Tsui, Edmund, Blazes, Marian, Thorne, Jennifer E, Okada, Annabelle A, Smith, Justine R, McCluskey, Peter J, Kempen, John H, Tappeiner, Christoph, Agarwal, Manisha, Bodaghi, Bahram, Nguyen, Quan Dong, Gupta, Vishali, De Smet, Marc D, Zierhut, Manfred, and Pavesio, Carlos

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Clinical Research, Good Health and Well Being, COVID-19, Clinical Decision-Making, Consensus, Cross-Sectional Studies, Glucocorticoids, Humans, Immunomodulation, Immunosuppressive Agents, Practice Guidelines as Topic, Risk Assessment, SARS-CoV-2, Surveys and Questionnaires, Uveitis, Choroid, Imaging, Inflammation, Telemedicine, Conjunctiva, Immunology, Macula, Retina, Infection, Iris, Treatment medical, Epidemiology, Cornea, Vitreous, Treatment lasers, Ciliary body, Drugs, COVID-19 IMT Study Group, Opthalmology and Optometry, Public Health and Health Services, Ophthalmology & Optometry, Clinical sciences, Ophthalmology and optometry
Abstract

BackgroundImmunomodulatory therapy (IMT) is often considered for systemic treatment of non-infectious uveitis (NIU). During the evolving coronavirus disease-2019 (COVID-19) pandemic, given the concerns related to IMT and the increased risk of infections, an urgent need for guidance on the management of IMT in patients with uveitis has emerged.MethodsA cross-sectional survey of international uveitis experts was conducted. An expert steering committee identified clinical questions on the use of IMT in patients with NIU during the COVID-19 pandemic. Using an interactive online questionnaire, guided by background experience and knowledge, 139 global uveitis experts generated consensus statements for IMT. In total, 216 statements were developed around when to initiate, continue, decrease and stop systemic and local corticosteroids, conventional immunosuppressive agents and biologics in patients with NIU. Thirty-one additional questions were added, related to general recommendations, including the use of non-steroidal anti-inflammatory drugs (NSAIDs) and hydroxychloroquine.ResultsHighest consensus was achieved for not initiating IMT in patients who have suspected or confirmed COVID-19, and for using local over systemic corticosteroid therapy in patients who are at high-risk and very high-risk for severe or fatal COVID-19. While there was a consensus in starting or initiating NSAIDs for the treatment of scleritis in healthy patients, there was no consensus in starting hydroxychloroquine in any risk groups.ConclusionConsensus guidelines were proposed based on global expert opinion and practical experience to bridge the gap between clinical needs and the absence of medical evidence, to guide the treatment of patients with NIU during the COVID-19 pandemic.

Published
2021

21. Ocular tuberculosis (OTB): typical and atypical phenotypes in a UK setting

Author

Liang Peng, Claudia, primary, Hatem, Osman, additional, Manalan, Kavina, additional, Testi, Ilaria, additional, Charanjit, Sethi, additional, Dixit, Bhavini, additional, Martin, Laura, additional, Coleman, Meg, additional, Pavesio, Carlos, additional, Petrushkin, Harry, additional, Akshikar, Rashmi, additional, and Kon, Onn Min, additional

Published
2023
Full Text
View/download PDF

23. Choroidal Involvement in a Case of Viral Retinitis.

Author

Veeramani, Pratibha, Testi, Ilaria, Rasheed, Rajna, Westcott, Mark, and Pavesio, Carlos

Subjects
*CHOROID diseases, *OPTICAL coherence tomography, *DIAGNOSTIC imaging
Abstract

Purpose: To describe a challenging case of acute retinal necrosis. Methods: Clinical data, including medical history, clinical findings and imaging features were retrospectively collected in a 28-year-old female with unilateral active retinitis. Results: The yellowish area of retinitis surrounding a pigmented chorioretinal scar and the full thickness retinal hyper-reflectivity associated with diffuse increase in choroidal demonstrated a challenging case of necrotising retinitis, where baseline clinical and tomographic features were atypical and misleading towards a toxoplasmic aetiology. The detection of virus genome in ocular samples was necessary to achieve a correct diagnosis of acute retinal necrosis. Conclusion: Although rare, choroidal involvement may occur in acute retinal necrosis along with the wellknown retinal features. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Diagnostic and Therapeutic Challenges

Author

Agarwal, Aniruddha, Testi, Ilaria, Prakash, Gaurav, Sharma, Suryaprakash, Sehgal, Shobha, Kapila, Aastha Takkar, Gupta, Nalini, Lal, Vivek, Gupta, Vishali, Welch, R. Joel, and Park, Susanna S.

Published
2020
Full Text
View/download PDF

26. Ocular Toxoplasmosis.

Author

Goh, Eunice Jin Hui, Putera, Ikhwanuliman, La Distia Nora, Rina, Mahendradas, Padmamalini, Biswas, Jyotirmay, Chee, Soon-Phaik, Testi, Ilaria, Pavesio, Carlos E, Curi, Andre Luiz Land, Vasconcelos-Santos, Daniel Vitor, Arora, Atul, Gupta, Vishali, de-la-Torre, Alejandra, and Agrawal, Rupesh

Subjects
TOXOPLASMOSIS, IRIDOCYCLITIS, VISION disorders, LITERARY sources, AGE groups, UVEITIS
Abstract

Introduction: Ocular toxoplasmosis is the leading cause of posterior uveitis worldwide, affecting individuals acrossdifferent age groups. The key to reducing vision loss includes prompt diagnosis and treatment. However, despite the prevalence of ocular toxoplasmosis, there has been little consensus regarding its pathophysiology,clinical features, diagnosis, and especially management. Methods: The data sources were literature reviews, including Pub Med and Medline databases. Search terms included toxoplasmosis, retinitis, vasculitis, vitritis, uveitis alone or in combination with, serum, aqueous, vitreous eye, ocular and review. Results: In this review paper, we have sought to provide an overview of the pathophysiology, epidemiology, and clinical features of the disease, both based on current literature and our own clinical experience. We have also discussed the use of serology, ocular fluid, and ophthalmic investigations that could further facilitate the diagnosis of ocular toxoplasmosis.Different management strategies have been reported worldwide, including newer approaches such as local therapy. Conclusion: A better understanding of critical aspects of ocular toxoplasmosis will hopefully lead to reduced morbidity, including blindness associated with this condition. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

30. Ocular Inflammatory Events Following COVID-19 Vaccination in the Paediatric Population: A Multinational Case Series.

Author

Testi, Ilaria, Brandão-de-Resende, Camilo, De-La-Torre, Alejandra, Concha-Del-Rio, Luz Elena, Cheja-Kalb, Rashel, Mahendradas, Padmamalini, Habot-Wilner, Zohar, Yalçındağ, Nilüfer, Markelj, Špela, Iriqat, Salam, Portero, Alejandro, Petrushkin, Harry, Pavesio, Carlos, and Solebo, Ameenat Lola

Abstract

Background Methods Results Conclusion Ocular inflammatory events following COVID-19 vaccination have been reported in the adult population.Multinational case series of patients under the age of 18 diagnosed with ocular inflammatory events within 28 days of COVID-19 vaccination.Twenty individuals were included. The most common event was anterior uveitis (n = 8, 40.0%), followed by intermediate uveitis (7 patients, 35%), panuveitis (4 patients, 20%), and posterior uveitis (1 patient, 5%). The event was noticed in the first week after vaccination in 11 patients (55.0%). Twelve patients (60.0%) had a previous history of intraocular inflammatory event. Patients were managed with topical corticosteroids (n = 19, 95.0%), oral corticosteroids (n = 10, 50.0%), or increased dose of immunosuppressive treatment (n = 6, 30.0%). Thirteen patients (65.0%) had a complete resolution of the ocular event without complications. All patients had a final visual acuity unaffected or less than three lines of loss.Ocular inflammatory events may happen in the paediatric population following COVID-19 vaccination. Most events were successfully treated, and all showed a good visual outcome. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

31. Ocular Toxoplasmosis

Author

Goh, Eunice Jin Hui, primary, Putera, Ikhwanuliman, additional, La Distia Nora, Rina, additional, Mahendradas, Padmamalini, additional, Biswas, Jyotirmay, additional, Chee, Soon-Phaik, additional, Testi, Ilaria, additional, Pavesio, Carlos E, additional, Curi, Andre Luiz Land, additional, Vasconcelos-Santos, Daniel Vitor, additional, Arora, Atul, additional, Gupta, Vishali, additional, de-la-Torre, Alejandra, additional, and Agrawal, Rupesh, additional

Published
2022
Full Text
View/download PDF

33. The Collaborative Ocular Tuberculosis Study (COTS) calculator—a consensus-based decision tool for initiating antitubercular therapy in ocular tuberculosis

Author

Agrawal, Rupesh, primary, Ludi, Zhang, additional, Betzler, Bjorn K., additional, Testi, Ilaria, additional, Mahajan, Sarakshi, additional, Rousellot, Andres, additional, Kempen, John H., additional, Smith, Justine R., additional, McCluskey, Peter, additional, Nguyen, Quan Dong, additional, Pavesio, Carlos, additional, and Gupta, Vishali, additional

Published
2022
Full Text
View/download PDF

34. Resolution of Isolated Subretinal Abscess with Systemic Antibiotic Treatment.

Author

Gallo, Beatrice, Testi, Ilaria, Clare, Gerry, and Pavesio, Carlos

Subjects
*ABSCESSES, *THERAPEUTICS, *ANTIBIOTICS, *VISUAL acuity, *OPTICAL coherence tomography
Abstract

To describe clinical features and therapeutic management of a case of isolated subretinal abscess (SRA) in an immunocompetent male patient with no predisposing conditions or risk factors. Clinical data, including medical history, clinical findings and results of systemic investigations, were retrospectively collected in a 40-year-old man diagnosed with unilateral focal SRA. Systemic investigations did not reveal any extraocular infective focus. Prompt diagnosis of SRA and aggressive systemic antibiotic treatment averted breakthrough into the vitreous cavity and led to clinical resolution with preservation of visual acuity. No local recurrences or distal spread of the infection were found at follow-up. In isolated SRA, timely systemic antibiotic treatment can lead to an excellent clinical outcome. Close monitoring is essential to prevent potential progression of SRA to a sight-threatening endophthalmitis, which would prompt an urgent shift in the therapeutic approach. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

35. Ocular tuberculosis: Where are we today?

Author

Testi, Ilaria, Agrawal, Rupesh, Mehta, Salil, Basu, Soumvaya, Nguyen, Quan, Pavesio, Carlos, and Gupta, Vishali

Subjects
Ophthalmic research, Tuberculosis -- Diagnosis -- Care and treatment, Eye diseases -- Diagnosis -- Care and treatment, Health
Abstract

Byline: Ilaria. Testi, Rupesh. Agrawal, Salil. Mehta, Soumvaya. Basu, Quan. Nguyen, Carlos. Pavesio, Vishali. Gupta Diagnosis and management of ocular tuberculosis (OTB) poses a significant challenge. Mixed ocular tissue involvement [...]

Published
2020

38. Reply

Author

Agrawal, Rupesh, primary, Testi, Ilaria, additional, Agarwal, Aniruddha, additional, Nguyen, Quan Dong, additional, Pavesio, Carlos, additional, and Gupta, Vishali, additional

Published
2021
Full Text
View/download PDF

41. Management of ocular tuberculosis(OTB): The role of CT and Positron Emission Tomography(PET) imaging

Author

Manalan, Kavina, primary, Testi, Ilaria, additional, Dixit, Bhavini, additional, Payadachee, Yorissa, additional, Sethi, Charanjit, additional, Martin, Laura, additional, Russell, Georgina, additional, Addison, Peter, additional, Pavesio, Carlos, additional, Petrushkin, Harry, additional, Akshikar, Rashmi, additional, and Kon, Onn Min, additional

Published
2021
Full Text
View/download PDF

42. Ocular Adverse Events After COVID-19 Vaccination

Author

Ng, Xin Le, primary, Betzler, Bjorn Kaijun, additional, Testi, Ilaria, additional, Ho, Su Ling, additional, Tien, Melissa, additional, Ngo, Wei Kiong, additional, Zierhut, Manfred, additional, Chee, Soon Phaik, additional, Gupta, Vishali, additional, Pavesio, Carlos E, additional, de Smet, Marc D., additional, and Agrawal, Rupesh, additional

Published
2021
Full Text
View/download PDF

43. Antiviral Therapy for Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV)-Induced Anterior Uveitis: A Systematic Review and Meta-Analysis

Author

Testi, Ilaria, primary, Aggarwal, Kanika, additional, Jaiswal, Nishant, additional, Dahiya, Neha, additional, Thng, Zheng Xian, additional, Agarwal, Aniruddha, additional, Ahuja, Alka, additional, Duggal, Mona, additional, Kankaria, Ankita, additional, Ling Ho, Su, additional, Chee, Soon-Paik, additional, Westcott, Mark, additional, Pavesio, Carlos, additional, Agrawal, Rupesh, additional, and Gupta, Vishali, additional

Published
2021
Full Text
View/download PDF

44. Hypotony in uveitis: an overview of medical and surgical management

Author

Testi, Ilaria, Calcagni, Antonio, Barton, Keith, Gooch, James, and Petrushkin, Harry

Abstract

Hypotony is a well-recognised, sight-threatening complication of uveitis. It can also be the final common endpoint for a multitude of disease entities. Multiple mechanisms underlie hypotony, and meticulous clinical history alongside ocular phenotyping is necessary for choosing the best intervention and therapeutic management. In this narrative review, a comprehensive overview of medical and surgical treatment options for the management of non-surgically induced hypotony is provided. Management of ocular hypotony relies on the knowledge of the aetiology and mechanisms involved. An understanding of disease trajectory is vital to properly educate patients. Both anatomical and functional outcomes depend on the underlying pathophysiology and choice of treatment.

Published
2023
Full Text
View/download PDF

45. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis

Author

Agrawal, Rupesh, Testi, Ilaria, Bodaghi, Baharam, Barisani-Asenbauer, Talin, McCluskey, Peter, Agarwal, Aniruddha, Kempen, John H, Gupta, Amod, Smith, Justine R, de Smet, Marc D, Yuen, Yew Sen, Mahajan, Sarakshi, Kon, Onn Min, Nguyen, Quan Dong, Pavesio, Carlos, and Gupta, Vishali

Subjects
education, 610 Medicine & health
Abstract

TOPIC The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to develop evidence- and experience-based guidelines for the management of tubercular uveitis (TBU). CLINICAL RELEVANCE The absence of international agreement on the use of antitubercular therapy (ATT) in patients with TBU contributes to a significant heterogeneity in the approach to the management of this condition. METHODS Consensus statements for the initiation of ATT in TBU were generated using a 2-step modified Delphi technique. In Delphi step 1, a smart web-based survey based on background evidence from published literature was prepared to collect the opinion of 81 international experts on the use of ATT in different clinical scenarios. The survey included 324 questions related to tubercular anterior uveitis (TAU), tubercular intermediate uveitis (TIU), tubercular panuveitis (TPU), and tubercular retinal vasculitis (TRV) administered by the experts, after which the COTS group met in November 2019 for a systematic and critical discussion of the statements in accordance with the second round of the modified Delphi process. RESULTS Forty-four consensus statements on the initiation of ATT in TAU, TIU, TPU, and TRV were obtained, based on ocular phenotypes suggestive of TBU and corroborative evidence of tuberculosis, provided by several combinations of immunologic and radiologic test results. Experts agreed on initiating ATT in recurrent TAU, TIU, TPU, and active TRV depending on the TB endemicity. In the presence of positive results for any 1 of the immunologic tests along with radiologic features suggestive of past evidence of tuberculosis infection. In patients with a first episode of TAU, consensus to initiate ATT was reached only if both immunologic and radiologic test results were positive. DISCUSSION The COTS consensus guidelines were generated based on the evidence from published literature, specialists' opinions, and logic construction to address the initiation of ATT in TBU. The guidelines also should inform public policy by adding specific types of TBU to the list of conditions that should be treated as tuberculosis.

Published
2021
Full Text
View/download PDF

46. Diagnostic value of culture results from aqueous tap versus vitreous tap in cases of bacterial endophthalmitis.

Author

AlBloushi, Abdulrahman F., Ajamil-Rodanes, Sofia, Testi, Ilaria, Wagland, Catherine, Grant-McKenzie, Nadine, and Pavesio, Carlos

Abstract

Objective To investigate the concordance between aqueous and vitreous tap culture results among different types of bacterial endophthalmitis. Methods and analysis This retrospective cohort analysis included all cases diagnosed with endophthalmitis at Moorfields Eye Hospital between January 2008 and March 2020. Aqueous and vitreous samples obtained simultaneously at presentation. Samples were evaluated for sensitivity, specificity, negative and positive predictive values. Results A total of 217 patients (217 eyes) were included in the study. Postsurgical endophthalmitis was the most common type of endophthalmitis and diagnosed in 35.9% of the cases. The rate of positive culture results was 32.2% from vitreous tap and 21.7% from aqueous tap. The culture yield through vitreous sampling was 15.7% when aqueous culture results were negative, and in 5.1%, the aqueous sample was positive when the vitreous tap results were negative. Considering the vitreous tap as the gold standard, aqueous sample culture results showed a statistically significant high specificity and positive predictive values in cases of postsurgical endophthalmitis, late-onset endophthalmitis associated with glaucoma procedures, postintravitreal injection and endophthalmitis associated with bacterial keratitis. Coagulase Negative Staphylococcus was the most common organism isolated from vitreous and aqueous samples. Conclusions Even though the sensitivity and specificity of aqueous tap are low, our results show that in a few cases it identified important organisms, otherwise missed by vitreous sampling alone. Culture of vitreous sample remains the gold standard for isolation of pathogen in bacterial endophthalmitis, but aqueous samples should also be obtained as an adjunct for the diagnosis. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

49. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1

Author

Agrawal, Rupesh, primary, Testi, Ilaria, additional, Mahajan, Sarakshi, additional, Yuen, Yew Sen, additional, Agarwal, Aniruddha, additional, Kon, Onn Min, additional, Barisani-Asenbauer, Talin, additional, Kempen, John H., additional, Gupta, Amod, additional, Jabs, Douglas A., additional, Smith, Justine R., additional, Nguyen, Quan Dong, additional, Pavesio, Carlos, additional, Gupta, Vishali, additional, Agarwal, Mamta, additional, Agarwal, Manisha, additional, Aggarwal, Ashutosh, additional, Aggarwal, Kanika, additional, Agrawal, Mukesh, additional, Al-Dhibi, Hassan, additional, Androudi, Sofia, additional, Asyari, Fatma, additional, Balasundaram, Manohar Babu, additional, Murthy, Kalpana Babu, additional, Baglivo, Edoardo, additional, Banker, Alay, additional, Bansal, Reema, additional, Basu, Soumyava, additional, Behera, Digamber, additional, Biswas, Jyotirmay, additional, Bodaghi, Bahram, additional, Carreño, Ester, additional, Caspers, Laure, additional, Chee, Soon Phaik, additional, Chhabra, Romi, additional, Cimino, Luca, additional, Concha del Rio, Luz Elena, additional, Cunningham, Emmett T., additional, Land Curi, Andrè Luiz, additional, Das, Dipankar, additional, Davis, Janet, additional, DeSmet, Marc, additional, Denisova, Ekaterina, additional, Denniston, Alastair K., additional, Errera, Marie-Hélène, additional, Fonollosa, Alejandro, additional, George, Amala, additional, Goldstein, Debra A., additional, Crosier, Yan Guex, additional, Gunasekeran, Dinesh Visva, additional, Gurbaxani, Avinash, additional, Invernizzi, Alessandro, additional, Isa, Hazlita M., additional, Islam, Shah Md., additional, Jones, Nicholas, additional, Katoch, Deeksha, additional, Khairallah, Moncef, additional, Khosla, Amit, additional, Kramer, Michal, additional, Kumar, Amitabh, additional, Kumar, Atul, additional, La Distia Nora, Rina, additional, Lee, Richard, additional, Lowder, Careen, additional, Luthra, Saurabh, additional, Mahendradas, Padmamalini, additional, Makhoul, Dorine, additional, Mazumdar, Shahana, additional, McCluskey, Peter, additional, Mehta, Salil, additional, Miserocchi, Elisabetta, additional, Mochizuki, Manabu, additional, Mohamed, Oli S., additional, Muccioli, Cristina, additional, Munk, Marion R., additional, Murthy, Somasheila, additional, Narain, Shishir, additional, Nascimento, Heloisa, additional, Neri, Piergiorgio, additional, Nguyen, Myhanh, additional, Okada, Annabelle A., additional, Ozdal, Pinar, additional, Palestine, Alan, additional, Pichi, Francesco, additional, Raje, Dhananjay, additional, Rathinam, S.R., additional, Rousselot, Andres, additional, Schlaen, Ariel, additional, Sehgal, Shobha, additional, Sen, H. Nida, additional, Sharma, Aman, additional, Sharma, Kusum, additional, Shoughy, Samir S., additional, Singh, Nirbhai, additional, Singh, Ramandeep, additional, Soheilian, Masoud, additional, Sridharan, Sudharshan, additional, Thorne, Jennifer E., additional, Tappeiner, Christoph, additional, Teoh, Stephen, additional, Tognon, Maria Sofia, additional, Tugal-Tutkun, Ilknur, additional, Tyagi, Mudit, additional, Uy, Harvey, additional, Vasconcelos Santos, Daniel Vitor, additional, Valentincic, Natasa Vidovic, additional, Westcott, Mark, additional, Yanai, Ryoji, additional, Alvarez, Bety Yanez, additional, Zahedur, Rahman, additional, and Zierhut, Manfred, additional

Published
2021
Full Text
View/download PDF

50. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2

Author

Agrawal, Rupesh, primary, Testi, Ilaria, additional, Bodaghi, Baharam, additional, Barisani-Asenbauer, Talin, additional, McCluskey, Peter, additional, Agarwal, Aniruddha, additional, Kempen, John H., additional, Gupta, Amod, additional, Smith, Justine R., additional, de Smet, Marc D., additional, Yuen, Yew Sen, additional, Mahajan, Sarakshi, additional, Kon, Onn Min, additional, Nguyen, Quan Dong, additional, Pavesio, Carlos, additional, Gupta, Vishali, additional, Agrawal, Rupesh, additional, Agarwal, Mamta, additional, Agarwal, Manisha, additional, Aggarwal, Ashutosh, additional, Aggarwal, Kanika, additional, Agrawal, Mukesh, additional, Al-Dhibi, Hassan, additional, Androudi, Sofia, additional, Asyari, Fatma, additional, Balasundaram, Manohar Babu, additional, Murthy, Kalpana Babu, additional, Baglivo, Edoardo, additional, Banker, Alay, additional, Bansal, Reema, additional, Basu, Soumyava, additional, Behera, Digamber, additional, Biswas, Jyotirmay, additional, Carreño, Ester, additional, Caspers, Laure, additional, Chee, Soon Phaik, additional, Chhabra, Romi, additional, Cimino, Luca, additional, Concha del Rio, Luz Elena, additional, Cunningham, Emmett T., additional, Land Curi, Andrè Luiz, additional, Das, Dipankar, additional, Davis, Janet, additional, DeSmet, Marc, additional, Denisova, Ekaterina, additional, Denniston, Alastair K., additional, Errera, Marie-Hélène, additional, Fonollosa, Alejandro, additional, George, Amala, additional, Goldstein, Debra A., additional, Crosier, Yan Guex, additional, Gunasekeran, Dinesh Visva, additional, Gurbaxani, Avinash, additional, Invernizzi, Alessandro, additional, Isa, Hazlita M., additional, Islam, Shah M.d., additional, Jones, Nicholas, additional, Katoch, Deeksha, additional, Khairallah, Moncef, additional, Khosla, Amit, additional, Kramer, Michal, additional, Kumar, Amitabh, additional, Kumar, Atul, additional, La Distia Nora, Rina, additional, Lee, Richard, additional, Lowder, Careen, additional, Luthra, Saurabh, additional, Mahendradas, Padmamalini, additional, Makhoul, Dorine, additional, Mazumdar, Shahana, additional, Mehta, Salil, additional, Miserocchi, Elisabetta, additional, Mochizuki, Manabu, additional, Mohamed, Oli S., additional, Muccioli, Cristina, additional, Munk, Marion R., additional, Murthy, Somasheila, additional, Narain, Shishir, additional, Nascimento, Heloisa, additional, Neri, Piergiorgio, additional, Nguyen, Myhanh, additional, Okada, Annabelle A., additional, Ozdal, Pinar, additional, Palestine, Alan, additional, Pichi, Francesco, additional, Raje, Dhananjay, additional, Rathinam, S.R., additional, Rousselot, Andres, additional, Schlaen, Ariel, additional, Sehgal, Shobha, additional, Nida Sen, H., additional, Sharma, Aman, additional, Sharma, Kusum, additional, Shoughy, Samir S., additional, Singh, Nirbhai, additional, Singh, Ramandeep, additional, Soheilian, Masoud, additional, Sridharan, Sudharshan, additional, Thorne, Jennifer E., additional, Tappeiner, Christoph, additional, Teoh, Stephen, additional, Tognon, Maria Sofia, additional, Tugal-Tutkun, Ilknur, additional, Tyagi, Mudit, additional, Uy, Harvey, additional, Vasconcelos Santos, Daniel Vitor, additional, Valentincic, Natasa Vidovic, additional, Westcott, Mark, additional, Yanai, Ryoji, additional, Alvarez, Bety Yanez, additional, Zahedur, Rahman, additional, Zierhut, Manfred, additional, and Xian, Zheng, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results